Intermittent Androgen Suppression Therapy for Prostate Cancer Patients: A Choice for Improved Quality of Life?

QR Code

Intermittent Androgen Suppression Therapy for Prostate Cancer Patients: A Choice for Improved Quality of Life?

None

Saved in:

Bibliographic Details
Main Authors:	Hamilton, Gerhard, Olszewski-Hamilton, Ulrike, Theyer, Gerhard
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2011
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/24256
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Intermittent androgen therapy in prostate cancer reveals the pro-apoptotic roles of androgen/androgen receptor: an overview
by: Saleh Altuwaijri, et al.
Published: (2025-03-01)

Cytokeratin 18 (CK18) and CK18 Fragments for Detection of Minimal Residual Disease in Colon Cancer Patients
by: Olszewski-Hamilton, Ulrike, et al.
Published: (2012)

Androgen Deprivation Therapy for Prostate Cancer
by: Ziaran, Stanislav
Published: (2011)

Cytokeratin 18 (CK18) and Caspase-Cleaved CK18 (ccCK18) as Response Markers in Anticancer Therapy
by: Gerhard, Hamilton
Published: (2012)

Androgen Receptor Signalling in Prostate Cancer: Mechanisms of Resistance to Endocrine Therapies
by: Quistini A, et al.
Published: (2025-06-01)

Skeletal Scintigraphy in Assesing the Response of Prostate Cancer Metastases to Androgen Deprivation Therapy
by: S. P. Mironov, et al.
Published: (2021-09-01)

Stem Like Cells and Androgen Deprivation in Prostate Cancer
by: Tang, Yao, et al.
Published: (2011)

HIF1α-PHD1-FOXA1 Axis Orchestrates Hypoxic Reprogramming and Androgen Signaling Suppression in Prostate Cancer
by: Limiao Liang, et al.
Published: (2025-07-01)

Inhibition of Advanced Prostate Cancer by Androgens and Liver X Receptor Agonists
by: Chuu, Chih-Pin, et al.
Published: (2011)

Dissecting the roles of the androgen receptor in prostate cancer from molecular perspectives
by: Jieping Hu, et al.
Published: (2017-04-01)

Association between the molecular markers, effect and time of response to the androgen-deprivation therapy in patients with prostate cancer
by: L. V. Spirina, et al.
Published: (2019-04-01)

DRUG THERAPY FOR ANDROGEN-POSITIVE BREAST CANCER
by: A. D. Zikiryakhodjhaev, et al.
Published: (2021-03-01)

Bone Health Management in Men Commencing Androgen Deprivation Therapy for Prostate Cancer and Women Commencing Anti‐Oestrogen Therapy for Breast Cancer
by: Ian Liang, et al.
Published: (2025-05-01)

Influence of obesity and androgen deficiency on prostatic blood circulation
by: I. A. Tyuzikov, et al.
Published: (2012-04-01)

Case Report: Surgical androgen deprivation therapy for prostate cancer in a patient with concurrent scrotal paget’s disease
by: Sinan Yang, et al.
Published: (2025-06-01)

Androgen Deprivation Therapy–Induced Muscle Loss and Fat Gain Predict Cardiovascular Events in Prostate Cancer Patients
by: Jie Lee, et al.
Published: (2025-06-01)

FUNCTIONAL AND MORPHOMETRIC EVALUATION OF PROSTATE MICROCIRCULATION FOLLOWING HIGH-INTENSITY FOCUSED ULTRASOUND THERAPY WITH ANDROGEN DEPRIVATION FOR PROSTATIC ADENOCARCINOMA
by: V. P. Levin, et al.
Published: (2019-02-01)

Prostate Cancer Progression to Androgen Independent Disease: The Role of the Wnt/β-Catenin Pathway
by: Ha, Jacqueline R., et al.
Published: (2011)

Quality of Life of Patients with Hormone Refractory Prostate Cancer After Gene Therapy
by: Gotoh, Akinobu, et al.
Published: (2011)

New Approaches Targeting Androgen Receptor Signal Pathways for Treatment of Castration-Resistant Prostate Cancer
by: Donkena, et al.
Published: (2011)

Functional interaction of fibroblast growth factor 8b and androgen in prostate cancer cell proliferation
by: Wen-jun Xiao, et al.
Published: (2017-04-01)

Senescence-associated lncRNAs indicate distinct molecular subtypes associated with prognosis and androgen response in patients with prostate cancer
by: Dechao Feng, et al.
Published: (2023-07-01)

A Review of Quality of Life Following Treatments for Localized Prostate Cancer
by: Shoji, Sunao
Published: (2011)

Helping Patients Make Treatment Choices for Localized Prostate Cancer
by: Mohan, Ravinder, et al.
Published: (2012)

Intermittent intravenous ibandronate therapy for osteoporosis
by: L I Alekseeva, et al.
Published: (2008-09-01)

The urgency of the androgenic screening for men who underwent preventive medical examination for prostate diseases detection
by: A. A. Kamalov, et al.
Published: (2012-12-01)

Efficacy and Safety of Combined Androgen Deprivation Therapy (ADT) and Docetaxel Compared with ADT Alone for Metastatic Hormone-Naive Prostate Cancer: A Systematic Review and Meta-Analysis.
by: Tobias Engel Ayer Botrel, et al.
Published: (2016-01-01)

Prostate-Specific Antigen Reduction After Androgen Receptor Pathway Inhibitor Initiation: Real-World Comparison of Disease Progression Among Patients With Metastatic Castration-Sensitive Prostate Cancer
by: Shawn Du, et al.
Published: (2025-07-01)

Cardiovascular Effects of Androgens
by: Wilson, Carlos, et al.
Published: (2011)

Androgens and Vascular Function
by: Ferrer, Mercedes
Published: (2011)

Structural Retinal and Optic Nerve Changes in Prostate Cancer Patients Receiving Androgen Receptor Pathway Inhibitors: An OCT-Based In Vivo Analysis
by: Yasemin Bakkal Temi, et al.
Published: (2025-07-01)

Androgen deprivation therapy and hormonal status in men with COVID-19
by: A. A. Kamalov, et al.
Published: (2023-01-01)

High-Intensity Focused Ultrasound (HIFU) - An Alternative Choice in Prostate Cancer Treatment
by: Maestroni, Umberto, et al.
Published: (2011)

Prostate Cancer: Current and Emerging Therapies
by: Godbole, Abhijit M., et al.
Published: (2011)

Visualizing androgen signaling and assessing its interaction with canonical Wnt signaling pathways in prostate development, morphogenesis, and regeneration.
by: Yao Mawulikplimi Adzavon, et al.
Published: (2025-06-01)

Induced Androgenic Embryogenesis in Cereals
by: Kahrizi, Danial, et al.
Published: (2012)

Effect of Androgens on Human Fascia
by: Caterina Fede, et al.
Published: (2025-06-01)

PHARMACOECONOMIC ASSESSMENT OF INTERMITTENT AND CONTINUOUS RENAL REPLACEMENT THERAPY
by: Yu. S. Polushin, et al.
Published: (2018-01-01)

‘Beyond Treatment’: Clinical and psychosocial predictors of health-related quality of life of patients with prostate cancer
by: Michael Effah Ntiamoah, et al.
Published: (2025-07-01)

MAIN MOLECULAR TARGETS FOR PROSTATE CANCER THERAPY
by: G. S. Krasnov, et al.
Published: (2016-02-01)